Not there yet: using data-driven methods to predict who becomes costly among low-cost patients with type 2 diabetes
Abstract Background Diabetes is a leading cause of Medicare spending; predicting which individuals are likely to be costly is essential for targeting interventions. Current approaches generally focus on composite measures, short time-horizons, or patients who are already high utilizers, whose costs...
Main Authors: | Julie C. Lauffenburger, Mufaddal Mahesri, Niteesh K. Choudhry |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Endocrine Disorders |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12902-020-00609-1 |
Similar Items
-
Healthcare cost associations of patients who use illicit drugs in Florida: a retrospective analysis
by: Jessica L. Ryan, et al.
Published: (2020-09-01) -
The cost of dying on Medicare: an analysis of expenditure data
by: House, Donald Reed
Published: (2005) -
Esophageal cancer treatment costs by phase of care and treatment modality, 2000‐2013
by: Angela C. Tramontano, et al.
Published: (2019-09-01) -
Treatment Patterns, Healthcare Resource Utilization, and Costs Among Medicare Patients with Multiple Sclerosis in Relation to Disease-Modifying Therapy and Corticosteroid Treatment
by: Marie Sanchirico, et al.
Published: (2018-12-01) -
Healthcare Expenditures Associated with Heart Failure in Saudi Arabia: A Cost of Illness Study
by: Ahmed Alghamdi, et al.
Published: (2021-08-01)